Nalaganje...
Current status on the place of FOLFIRINOX in metastatic pancreatic cancer and future directions
Pancreatic cancer (PC) incidence rates are rapidly increasing in developed countries, with half the patients being metastatic at diagnosis. For decades, fluorouracil, then gemcitabine regimens were the preferred palliative first-line options for fit patients with metastatic PC. FOLFIRINOX (a combina...
Shranjeno v:
| izdano v: | Therap Adv Gastroenterol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5557187/ https://ncbi.nlm.nih.gov/pubmed/28835777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X17713879 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|